SEC Accuses 3 Of Illicit Ariad Trades
By Brian Amaral · June 27, 2017, 2:47 PM EDT
Two former Ariad Pharmaceuticals Inc. employees and the husband of an employee were sued this week by securities regulators for allegedly trading and tipping on inside information about a cancer drug....
To view the full article, register now.